Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Non-Cash-Items" stands at -15.58 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.
Johnson & Johnson's third quarter result of -16.27 Billion USD for the item "Other Non Cash Items" represents a decrease of -19,469.05 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of -16.27 Billion USD for the item "Other Non Cash Items" represents a decrease of -1,413.16 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of -15.58 Billion USD for the item "Other Non Cash Items" represents a decrease of -909.09 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -17.85 Billion United States Dollars compared to the value the year prior.
The 1 year change is -17.85 Billion United States Dollars.
The 3 year change is -16.16 Billion United States Dollars.
The 5 year change is -14.69 Billion United States Dollars.
The 10 year change is -14.81 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Non Cash Items | 905,699,262,464.00 |
![]() | AbbVie Inc - Other Non Cash Items | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Non Cash Items | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Non Cash Items | 280,205,508,085.11 |
![]() | Novartis AG - Other Non Cash Items | 255,096,620,580.91 |